175 related articles for article (PubMed ID: 23292866)
21. Prognostic and predictive value of long non-coding RNA GAS5 and mircoRNA-221 in colorectal cancer and their effects on colorectal cancer cell proliferation, migration and invasion.
Liu L; Meng T; Yang XH; Sayim P; Lei C; Jin B; Ge L; Wang HJ
Cancer Biomark; 2018; 22(2):283-299. PubMed ID: 29630521
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-630 is a prognostic marker for patients with colorectal cancer.
Chu D; Zheng J; Li J; Li Y; Zhang J; Zhao Q; Wang W; Ji G
Tumour Biol; 2014 Oct; 35(10):9787-92. PubMed ID: 24981248
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of miR-195 correlates with lymph node metastasis and poor prognosis in colorectal cancer.
Wang X; Wang J; Ma H; Zhang J; Zhou X
Med Oncol; 2012 Jun; 29(2):919-27. PubMed ID: 21390519
[TBL] [Abstract][Full Text] [Related]
24. miR-199a-3p inhibits hepatocyte growth factor/c-Met signaling in renal cancer carcinoma.
Huang J; Dong B; Zhang J; Kong W; Chen Y; Xue W; Liu D; Huang Y
Tumour Biol; 2014 Jun; 35(6):5833-43. PubMed ID: 24609899
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of miR-92a correlates with tumor metastasis and poor prognosis in patients with colorectal cancer.
Zhou T; Zhang G; Liu Z; Xia S; Tian H
Int J Colorectal Dis; 2013 Jan; 28(1):19-24. PubMed ID: 22772712
[TBL] [Abstract][Full Text] [Related]
26. Regulation of microRNA-1288 in colorectal cancer: altered expression and its clinicopathological significance.
Gopalan V; Pillai S; Ebrahimi F; Salajegheh A; Lam TC; Le TK; Langsford N; Ho YH; Smith RA; Lam AK
Mol Carcinog; 2014 Feb; 53 Suppl 1():E36-44. PubMed ID: 24009195
[TBL] [Abstract][Full Text] [Related]
27. Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer.
Yu H; Gao G; Jiang L; Guo L; Lin M; Jiao X; Jia W; Huang J
Int J Clin Exp Pathol; 2013; 6(12):2904-11. PubMed ID: 24294377
[TBL] [Abstract][Full Text] [Related]
28. Up-regulation of microRNA-183-3p is a potent prognostic marker for lung adenocarcinoma of female non-smokers.
Xu F; Zhang H; Su Y; Kong J; Yu H; Qian B
Clin Transl Oncol; 2014 Nov; 16(11):980-5. PubMed ID: 24805982
[TBL] [Abstract][Full Text] [Related]
29. Expression of microRNA-142-3p in cervical cancer and its correlation with prognosis.
Li M; Li BY; Xia H; Jiang LL
Eur Rev Med Pharmacol Sci; 2017 May; 21(10):2346-2350. PubMed ID: 28617557
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-29b is a Novel Prognostic Marker in Colorectal Cancer.
Inoue A; Yamamoto H; Uemura M; Nishimura J; Hata T; Takemasa I; Ikenaga M; Ikeda M; Murata K; Mizushima T; Doki Y; Mori M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1410-8. PubMed ID: 25472644
[TBL] [Abstract][Full Text] [Related]
31. miR-199a-3p downregulation in thyroid tissues is associated with invasion and metastasis of papillary thyroid carcinoma.
Liu C; Xing M; Wang L; Zhang K
Br J Biomed Sci; 2017 Apr; 74(2):90-94. PubMed ID: 28367740
[TBL] [Abstract][Full Text] [Related]
32. High expression of microRNA-199a-5p is associated with superior clinical outcomes in patients with locally advanced rectal cancer.
Baek DW; Kim G; Kang BW; Kim HJ; Park SY; Park JS; Choi GS; Kang MK; Hur K; Kim JG
J Cancer Res Clin Oncol; 2020 Jan; 146(1):105-115. PubMed ID: 31781865
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of microRNA-423-3p indicates poor prognosis and promotes cell proliferation, migration, and invasion of lung cancer.
Wang R; Li G; Zhuang G; Sun S; Song Z
Diagn Pathol; 2019 Jun; 14(1):53. PubMed ID: 31164163
[TBL] [Abstract][Full Text] [Related]
34. miR-199a-5p confers tumor-suppressive role in triple-negative breast cancer.
Chen J; Shin VY; Siu MT; Ho JC; Cheuk I; Kwong A
BMC Cancer; 2016 Nov; 16(1):887. PubMed ID: 27842518
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of microRNA-183 in human colorectal cancer and its clinical significance.
Zhou T; Zhang GJ; Zhou H; Xiao HX; Li Y
Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):229-33. PubMed ID: 24150523
[TBL] [Abstract][Full Text] [Related]
36. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
[TBL] [Abstract][Full Text] [Related]
37. MiR-199a-3p regulates mTOR and c-Met to influence the doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Milazzo M; Chieco P; Negrini M; Calin GA; Grazi GL; Pollutri D; Croce CM; Bolondi L; Gramantieri L
Cancer Res; 2010 Jun; 70(12):5184-93. PubMed ID: 20501828
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-10b is a prognostic indicator in colorectal cancer and confers resistance to the chemotherapeutic agent 5-fluorouracil in colorectal cancer cells.
Nishida N; Yamashita S; Mimori K; Sudo T; Tanaka F; Shibata K; Yamamoto H; Ishii H; Doki Y; Mori M
Ann Surg Oncol; 2012 Sep; 19(9):3065-71. PubMed ID: 22322955
[TBL] [Abstract][Full Text] [Related]
39. MiR-199a-3p promotes gastric cancer progression by targeting ZHX1.
Wang Z; Ma X; Cai Q; Wang X; Yu B; Cai Q; liu B; Zhu Z; Li C
FEBS Lett; 2014 Nov; 588(23):4504-12. PubMed ID: 25448600
[TBL] [Abstract][Full Text] [Related]
40. MiRNAs as molecular biomarkers in stage II egyptian colorectal cancer patients.
Bahnassy AA; Salem SE; El-Sayed M; Khorshid O; Abdellateif MS; Youssef AS; Mohanad M; Hussein M; Zekri AN; Ali NM
Exp Mol Pathol; 2018 Dec; 105(3):260-271. PubMed ID: 30213464
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]